Chief executive and vice chairman Rajeev Nannapaneni lays bare the changing face of global pharma, explaining why Indian generics firms are scouting for new opportunities.
​Chief executive and vice chairman Rajeev Nannapaneni lays bare the changing face of global pharma, explaining why Indian generics firms are scouting for new opportunities. by Soban News (international And National News)
